Bioceres Crop Solutions (BIOX) EBIT (2016 - 2026)

Bioceres Crop Solutions has disclosed EBIT across 11 years of filings, most recently posting -$7.8 million for Q1 2026.

• In Q1 2026, EBIT fell 281.4% year-over-year to -$7.8 million; the TTM figure through Mar 2026 stood at -$8.0 million (down 125.28% YoY), while the FY2025 annual figure was -$2.2 million, down 104.88% from the prior year.
• EBIT came in at -$7.8 million for Q1 2026 at Bioceres Crop Solutions, down from $7.5 million in the prior quarter.
• In the past five years, EBIT ranged from a high of $29.9 million in Q1 2022 to a low of -$15.2 million in Q2 2022.
• Average EBIT over 5 years is $7.5 million, with a median of $7.2 million recorded in 2025.
• Year-over-year, EBIT jumped 659.0% in 2023 and plunged 281.4% in 2026.
• Over 5 years, EBIT stood at $2.2 million in 2022, then jumped by 659.0% to $16.8 million in 2023, then fell by 14.71% to $14.4 million in 2024, then tumbled by 47.63% to $7.5 million in 2025, then slumped by 203.69% to -$7.8 million in 2026.
• Per Business Quant data, the three most recent EBIT figures were -$7.8 million in Q1 2026, $7.5 million in Q4 2025, and $7.2 million in Q3 2025.